JME Group
Oral enzyme replacement therapy (Oral-ERT) and
non-viral gene replacement therapy for human and animal conditions.
Team Leadership
John Arvanitopoulos
Chief Executive Officer
Mr Arvanitopoulos working as CEO here at JME Group , he is responsible for the development of strategy and execution plans for JME Group presence in the US including new product introductions and creating strong partnerships with our customers. With 10 years of experience in healthcare, Mr Arvanitopoulos brings extensive expertise in marketing and operations, strategy, finance, and business development. Mr Arvanitopoulos has significant experience in the financial services industry, having held positions at Morgan WIlshire Securities , GBI Capital partners and Remax Reality.
Mr. Arvanitopoulos currently participates in various development stage private equity ventures and is President and CEO of Greco Management. He is also is a Licensed Real Estate broker in NY and has held Series 7 license – General Securities Representative.
Frank T. Martiniuk, PhD
Chief Science Officer
Frank Martiniuk currently our CSO at JME Group. A 40 year veteran of research and development , starting from his pre-Doctoral studies from 1976-1983 ,
Research Assistant Professor-1983 to 1992.
Director of Molecular Core Lab. in the General Clinical Research Center/CTSI-1992-2013.
New York University School of Medicine, Department of Medicine, Pulmonary Division/CTSI, 550 First Avenue, New York, NY 10016. Volunteer in the lab. of Kam-Meng Tchou-Wong PhD at the Department of Envirnomental Medicine-NYU School of Medicine, Tuxedo, NY, May 2013 to fall 2016. Research study advisor/consultant-Trixogensis. Prepare and design pre-clinical animals toxicity studies for various compounds. May 2014 to 2015 , Clinical research advisor/coordinator for Dr. William Levis and a pharmaceutical company. Organize and prepare IND/IRB/other documents for a clinical study for the treatment of leprosy. November 2013 to December 2015.
VP Research at iProdynamic Therapeutics, Inc. May 2013 to April 2017.
Eleni Arvanitopoulos
Chief Operating Officer
Ms. Elena Arvanitopoulos, is responsible for driving the continued growth of JME Group operations in Europe and International Regions. She is a Health Care professional with a strong clinical research background that includes operational and fiscal management planning of clinical trials Phases I-IV.
Elena has held various positions in both Public (NYU Langone Health) and Private Health Care sectors. (Pharmaceutical, CROs)
Experienced in recruitment for clinical trials and skilled in site selection process.
She has also owned and successfully operated a private business in Medical Billing.
Angelo Kambitsis
Chief Financial Officer
Mr Kambitsis is responsible for the overall Finance function of JME Group, that includes financial performance management, strategic planning and internal control. Mr Kambitsis businessman and entrepreneur, as our CFO he serves as the catalyst for successful marketing, customer loyalty and business development initiatives, complemented by high-caliber general management qualifications and a proven track record in delivering value to client organizations.
Creative, problem-solving analytical talents combine with P&L management and infrastructure development experience. along with strong communication skills and dynamic public speaking style. Currently Mr Kambtisis is serving as Director of Global Business Development and Head of Strategic Funds for the Asset Management division of K2 Properties . He also served as Managing Director for GRC Construction and BJB Group LLC in LIC NY some of the fastest growing Development companies in NYC.
Advisory Board
Scientific Board
-William Levis MD- Bellevue Hospital Center-ID and Dermatology
-Maryam Banikazemi MD-Associate Professor , Pediatrics-Boston Children's Hosp, NY Medical College ; Assoc Professor Metropolitan Hospital Section Chief , Genetics , NY -Treats AMD, Fabry's and DMD patients in NYC tristate area
- Stephanie Tzall PHD- Experience in research and AMD , Biotechnology
- Frank Martiniuk , PHD
- Eleni Arvanitopoulos, Clinical trials development
Patient Advocacy Board AMD patients
-
Greg Shoemaker
-
Hans Lundahl
-
Dennis Counts
-
Ryan Colburn
-
Sean Kelly
-
Sean Doerr